Home » Newsletters » BioWorld Science

BioWorld Science

July 6, 2001

View Archived Issues

Wyeth-Ayerst and Taxolog to develop novel taxanes

Licensing opportunity from NIH: novel vacuolar-type H+-ATPase inhibitors

Role for donepezil in the prophylaxis of migraine

Naratriptan superior to naproxen in prevention of menstrual migraine

New isoniazid derivative is a promising agent for TB

Susceptibility testing indicates no crossresistance for GAR-936 with other tetracyclines

Improved stability and in vivo activity achieved in novel human GLP-1 analogues

Amgen awaits FDA decision on ARANESP

CLX-090700: a synthetic analogue of a natural product with oral antidiabetic properties

New study data support lamotrigine as treatment for bipolar disorder

Pharmacological profile of AS-8112 suggests potential in emesis

Aphios and ITC/Immune Technology to develop natural therapeutic for hepatitis C

Corixa updates status of Melacine and Bexxar development programs

Additional beneficial effects reported for ezetimibe in a hamster model of combined dyslipidemia

Phytoestrogens attenuate Abeta-mediated neuronal toxicity

ISTA completes enrollment in second phase III study of Vitrase

Phytopharm's P-57 successfully completes second stage of obesity study

FDA grants approval for Debiopharm's Trelstar LA for use in advanced prostate cancer

WHI-P154 claimed for sensitizing cancer cells to radiation

Several series of antineoplastic agents presented by ADIR in patents

Enzyme-inducing sulfenate and thiosulfinate esters described by U.S. university

Alkoxyiminoalkanoic acid derivatives for the prevention, treatment of diabetes

Beta3-adrenoceptor agonists from Fujisawa particularly useful for urinary incontinence, pollakiuria

Steroid sulfatase inhibitors in development by Novartis for cancer, etc.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...